Zevra Therapeutics Inc. (ZVRA) — Capital Reinvestment Ratio
Latest as of September 2025:
0.12x
Zevra Therapeutics Inc. (ZVRA) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow ($4.71 Million) in capital expenditures ($554.00K). See Zevra Therapeutics Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
$4.71 Million
USD
Capital Expenditures
$554.00K
USD
Data as of
Sep 2025
Most recent filing
Zevra Therapeutics Inc. Capital Reinvestment Ratio (2021–2021)
This chart tracks Zevra Therapeutics Inc.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Zevra Therapeutics Inc. (2021–2021)
Year-by-year Capital Reinvestment Ratio for Zevra Therapeutics Inc. from 2021 to 2021. For live market cap and broader valuation context, see ZVRA market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | $10.44 Million | $102.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow